JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M003714200 on July 18, 2000

J. Biol. Chem., Vol. 275, Issue 39, 29960-29967, September 29, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/39/29960    most recent
M003714200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by March, M. E.
Right arrow Articles by Ravichandran, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by March, M. E.
Right arrow Articles by Ravichandran, K. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

p135 Src Homology 2 Domain-containing Inositol 5'-Phosphatase (SHIPbeta ) Isoform Can Substitute for p145 SHIP in Fcgamma RIIB1-mediated Inhibitory Signaling in B Cells*

Michael E. MarchDagger , David M. Lucas§, M. Javad AmanDagger , and Kodimangalam S. RavichandranDagger

From the Dagger  Beirne B. Carter Center for Immunology Research and the Department of Microbiology, University of Virginia, Charlottesville, Virginia 22908 and § Ohio State University, Department of Internal Medicine, Columbus, Ohio 43210

The inositol 5'-phosphatase, SHIP (also referred to as SHIP-1 or SHIPalpha ), is expressed in all cells of the hematopoietic lineage. Depending on the cell type being investigated and the state of differentiation, SHIP isoforms of several different molecular masses (170, 160, 145, 135, 125, and 110 kDa) have been seen in immunoblots. However, the function of the individual isoforms and the effect of expressing multiple isoforms simultaneously are not understood. Some of these SHIP isoforms have recently been characterized at the level of primary sequence. In this report, we investigated the function of the recently characterized 135-kDa SHIP isoform (SHIPbeta ), which appears to possess the catalytic domain but lacks some of the protein-protein interaction motifs at the C terminus. By reconstituting SHIP-deficient DT40 B cells with either SHIPbeta or the better-characterized p145 SHIPalpha , we addressed the function of SHIPbeta in the complete absence of SHIPalpha . We observed that SHIPbeta had enzymatic activity comparable with SHIPalpha and that SHIPbeta was able to reconstitute Fcgamma RIIB1-mediated inhibition of B cell receptor-induced signaling events such as calcium flux and Akt and mitogen-activated protein kinase activation. SHIPbeta was readily phosphorylated in response to B cell receptor cross-linking with the inhibitory receptor Fcgamma RIIB1 and SHIPbeta also interacted with the adapter protein Shc. During these studies we also observed that the SHIPalpha or SHIPbeta interaction with Grb2 is not required for Fcgamma RIIB1-mediated inhibition of calcium flux. These data suggest that SHIPbeta , which is normally expressed in B cells along with SHIPalpha , functions comparably with SHIPalpha and that these two isoforms are not likely to be antagonistic in their function in vivo.


* This work was supported by National Institutes of Health Grants A1-43425 and GM-55761 (to K. S. R.) and by National Research Service Award F32 DK09774-01 (to D. M. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Carter Immunology Center, Bldg. MR4, Rm. 4012F, HSC, University of Virginia, Charlottesville, VA 22908. Tel.: 804-243-6093; Fax: 804-924-1221; E-mail: kr4h@virginia.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Aman, A.-C. Tosello-Trampont, and K. Ravichandran
Fcgamma RIIB1/SHIP-mediated Inhibitory Signaling in B Cells Involves Lipid Rafts
J. Biol. Chem., November 30, 2001; 276(49): 46371 - 46378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Brauweiler, I. Tamir, S. Marschner, C. D. Helgason, and J. C. Cambier
Partially Distinct Molecular Mechanisms Mediate Inhibitory Fc{{gamma}}RIIB Signaling in Resting and Activated B Cells
J. Immunol., July 1, 2001; 167(1): 204 - 211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.